Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Jan 2022 for C4 Therapeutics, Inc., €18k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Marc A. Cohen: trading record in brief
Marc A. Cohen is a declared insider of C4 Therapeutics, Inc. (board member), with filings sourced from SEC (Form 4). In total, 4 filings cover trades dated from 14 June 2021 to 4 January 2022.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 18 January 2022: a share grant of €18k, in C4 Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Marc A. Cohen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
657 shares@ US$31.5834.2% of flowCommon StockSEC:0001209191-22-003503:0
461 shares@ US$44.9933.2% of flowCommon StockSEC:0001209191-21-059522:0
522 shares@ US$39.7232.6% of flowCommon StockSEC:0001209191-21-045807:0
92,817 shares0Common StockSEC:0001209191-21-040278:0
4 of 4 declarations
